CLINICAL_TRIALS
research
· 2024-11-20
Clinical Trial Update: Spinraza in Adult Spinal Muscular Atrophy
Summary
Clinical trial update showing Spinraza (nusinersen) being studied in adults with Spinal Muscular Atrophy, including SMA Type II and SMA Type III, with the study…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Spinal Muscular Atrophy, Spinal Muscular Atrophy Type II | Status: ACTIVE_NOT_RECRUITING